Michael Infante, an analyst from Morgan Stanley, maintained the Buy rating on Clearwater Analytics Holdings (CWAN – Research Report). The associated price target remains the same with $36.00.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Michael Infante has given his Buy rating due to a combination of factors highlighting Clearwater Analytics Holdings’ strong growth prospects. The recent fireside chat with CFO Jim Cox reinforced confidence in the company’s growth durability, both as a standalone entity and in its pro-forma state post-Enfusion acquisition. Infante notes that Clearwater is on track to exceed its high-end revenue expectations for the year, with a projected 21% organic growth rate, which aligns with prior forecasts.
Additionally, Clearwater has effectively executed $20 million in cost synergies, and the company anticipates that the terminal margins between Enfusion and Clearwater will be comparable at maturity. These factors, combined with the expectation of long-term EBITDA per share accretion, support the optimistic outlook. Infante’s analysis suggests that even under various revenue growth and margin scenarios, Clearwater remains well-positioned for continued financial success, justifying the Buy rating.
According to TipRanks, Infante is a 2-star analyst with an average return of 5.0% and a 55.56% success rate. Infante covers the Technology sector, focusing on stocks such as Clearwater Analytics Holdings, nCino, and Q2 Holdings.
In another report released on May 26, Wells Fargo also maintained a Buy rating on the stock with a $32.00 price target.
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue